Advertisement
Screener

IDEAYA Biosciences, Inc. (IDYA) Net Margin

IDEAYA Biosciences, Inc. (IDYA) Net Margin

  • 2026-06-30: Net Margin -1269.64%.
  • 2026-03-31: Net Margin -1502.12%.
  • 2025-12-31: Net Margin -765.66%.
  • 2025-09-30: Net Margin 57.37%.

Complete source-backed net margin history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-1269.64%
2026-03-31-1502.12%
2025-12-31-765.66%
2025-09-3057.37%
2024-12-31-1861.60%
2023-12-31-865.76%
2023-09-30-341.38%
2023-06-30-787.98%
2023-03-31-300.00%
2022-12-31-601.72%
2022-09-305.44%
2022-06-30-376.96%
2022-03-31-123.36%
2021-12-31-614.85%
2021-09-30-129.03%
2021-06-30-125.02%
2021-03-31-124.48%
2020-12-31-48.58%
2020-09-30-54.93%

Annual Net Margin

DateNet Margin
2025-12-31-51.99%
2024-12-31-3921.10%
2023-12-31-483.05%
2022-12-31-115.17%
2021-12-31-178.10%
2020-12-31-176.55%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53